Notably, decreased CSF cystatin C levels have been found to be a critical indicator of rapidly progressive dementia and Alzheimer’s disease, while elevated levels may suggest susceptibility to certain conditions like depression. This evidence concerns the gene CST3 and early-onset autosomal dominant Alzheimer disease.